Article | May 3, 2017

Bioburden Sources You Might Have Missed

Source: GE Healthcare Life Sciences

By David Westman, Global Product Marketing Manager BioProcess Chromatography Resins, GE Healthcare

Bioburden Sources You Might Have Missed

A problem with traditional mAb manufacturing is that there are so many potential entry points for microbial contamination. There are, however, ways to shut the door on contamination.

A complex issue

Monoclonal antibody (mAb) manufacturing is complex. This leads to many potential entry points for microbial contamination. What can you do to minimize the risk to patients—and your reputation?